Рекомендации международных согласительных документов по профилактике рака желудка и рецидивов гастродуоденальной язвы

1. Malfertheiner P, Megraud F, O'Morain C et al. Current concepts in the management of Helicobacter pylori infection – The Maastricht 2–2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167–80.
2. Malfertheiner P, Megraud F, O'Morain C et al. Current concepts in the management of Helicobacter pylori infection – The Maastricht III Consensus Report. Gut 2007; 56: 772–81.
3. Chey WD, Wong BCY. American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection. Am J Gastroenterol 2007; 102: 1808–25.
4. Ивашкин В.Т., Исаков В.А., Лапина Т.Л. Какие рекомендации по лечению заболеваний, ассоциированных с H.pylori, нужны в России? Анализ основных положений Маастрихтского соглашения-2. Библиотека последипломного образования. М., 2000.
5. Gisbert JP, De La Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 2006; 23: 35–44.
6. Megraud F, Lamouliatte H. Review article: the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther 2003; 17: 1333–43.
7. Lind T, Rydberg L, Kyleback A et al. Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14: 861–867.
8. Rohss K, Hasselgren G, Hedenstrom H. Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease. Dig Dis Sci 2002; 47: 954–958.
9. Miner P, Katz PO, Chen Y et al. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol 2003; 98: 2616–2620.
10. Gralnek I, Dulai G, Fennerty M, Spiegel B. Esomeprazole Versus Other Proton Pump Inhibitors in Erosive Esophagitis: A Meta-Analysis of Randomized Clinical Trials. Clin Gastroenterol Hepatol 2006; 4: 1452–8.
11. Wang X, Fang JY, Lu R, Sun DF. A meta-analysis: comparison of esomeprazole and other proton pump inhibitors in eradicating Helicobacter pylori. Digestion 2006; 73(2–3): 178–86.
12. Пиманов С.И., Макаренко Е.В., Королева Ю.И. Обоснование эмпирической эрадикационной терапии у больных язвенной болезнью двенадцатиперстной кишки. Клин. мед. 2006; 84(1): 74–6.
13. Dubois RW, Melmed GY, Henning JM, Laine L Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy. Aliment Pharmacol Ther 2004; 19: 197–208.
14. Scheiman JM, Cryer B, Asaka M et al. Panel discussion: treatment approaches to control gastrointestinal risk and balance cardiovascular risks and benefits: proposals and recommendations. Aliment Pharmacol Ther Symp Ser 2005; 1: 26–32.
15. Graham DY, Chan FKL. NSAIDs, Risks, and Gastroprotective Strategies: Current Status and Future. Gastroenterology 2008; 134: 1240–57.
16. Scheiman JM, Yeomans ND, Talley NJ et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 2006; 101(4): 701–10.
17. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007; 133: 659–72.
18. De Vries A, Van Grieken N, Looman C et al. Gastric Cancer Risk in Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study in the Netherlands Gastroenterology 2008; 134: 945–52.
19. Sakaki N, Kozawa H, Egawa N et al. Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings Aliment Pharmacol Ther 2002; 16: 198–203.
20. Hojo M, Miwa H, Ohkusa T et al. Alteration of histological gastritis after cure of Helicobacter pylori Infection Aliment Pharmacol Ther 2002; 16: 1923–32.
21.Пиманов С.И., Макаренко Е.В., Крылов Ю.В. и др. Влияние эрадикации Helicobacter pylori на морфологические изменения слизистой оболочки желудка. Арх. пат. 2006; 68(5): 22–7.
22. Wong BC, Lam SK, Wong WM et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187–94.
23. Leung WK, Lin SR, Ching JY et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004; 53: 1244–9.
24. Mera R, Fontham ET, Bravo LE et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005; 54: 1536–40.
25. Saito D, Boku N, Fujioka T et al. Impact of H. pylori eradication on gastric cancer prevention: endoscopic results of the Japanese intervention trial (JITHP-study), a randomized multi-center trial. Gastroenterology 2005; 128: A-4.
26. Take S, Mizuno M, Ishiki K et al. The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol 2005; 100: 1037–42.
27. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 639–42.
28. Zhou LY, Lin SR, Ding SG et al. The changing trends of the incidence of gastric cancer after Helicobacter pylori eradication in Shandong area. Chinese J Dig Dis 2005; 6: 114–5.
29. Kato M, Asaka M, Nakamura T et al. Helicobacter pylori eradication prevents the development of gastric cancer – results of a long-term retrospective study in Japan. Aliment Pharmacol Ther 2006; 24 (Suppl. 4): 203–6.
30. Takenaka R, Okada H, Kato J et al. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther 2007; 25: 805–12.
31. Malfertheiner P, Sipponen P, Naumann M et al. Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique. Am J Gastroenterol 2005; 100: 2100–15.
32. Fock KM, Talley NJ, Moayyedi P et al. Asia Pacific consensus guideline on gastric cancer prevention. J Gastroenterol Hepatol 2008; 23: 351–65.

С.И.Пиманов, Е.В.Макаренко, Е.В.Семенова, Ю.И.Королева